Clinical Trials › NCT04676204
Enrolling by Invitation
Relationship Between Oral DMT Burden and Adherence in MS
Sponsored by Monash University
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 323
Target enrollment
Sep 2020
Start date
Jul 2026
Expected completion
Interventions / Treatments
CladribineDimethyl fumarateFingolimodTeriflunomideOzanimodDiroximel fumarate
Conditions studied
Multiple Sclerosis
Trial locations
U.S. site locations haven't been posted yet for this trial. Check ClinicalTrials.gov for the latest contact and location info.
The app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.